FDA Guidance Provides New Details on Diversity Action Plans Required for Certain Clinical Studies
For Immediate Release: June 26, 2024 Today, the U.S. Food and Drug Administration issued a draft guidance, “Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies,” to assist medical product …